discovery tetracycline engendered enormous amount litigation late us government charged pfizer american cyanamid price fixing connection tetracycline related litigation lasted often series cases referred antibiotics litigation focal point case two companies settlement interference proceeding pto us patent trademark office priority respective applications tetracycline settlement american cyanamid acquired heyden chemicals pending tetracycline application conceded priority pfizer application withdrew application exchanged cross licenses pfizer according indictment american cyanamid bristol myers pfizer cyanamid knew tetracycline represented threat continuation dominant positions unreasonably high profits keep threat check indictment alleges cyanamid bought heydens rights development agreed help pfizer get tetracycline patent return charges justice department pfizer licensed cyanamid produce drug later avoid court fight might nullified patent pfizer cyanamid let bristolmyers federal trade commission found crosslicense combined fact pfizer withheld information knew known relevant patentability tetracycline constituted attempt pfizer american cyanamid share unlawful monopoly ultimately government lost government also sought cancel pfizer patent tetracycline alleging fraud concealment information would relevant patent examiner government lost final appeal case httpsenwikipediaorgwikitetracyclinelitigation